Effect of caffeic acid phenethyl ester on cartilage in experimental osteoarthritis

Rheumatology International

Volumn 22, Issue 6, 2002, Pages 222-226

  Elmali, Nurzat ^a,b   Ayan, Írfan ^a,b   Türköz, Yusuf ^a,b   Mizrak, Bülent ^a,b   Germen, Burak ^a,b   Bora, Arslan ^a,b  

^a INONU UNIVERSITY   (Turkey)

^b INONU UNIVERSITY   (Turkey)

Author keywords

Caffeic acid phenethyl ester; Nuclear factor kappa B; Osteoarthritis

Indexed keywords

ALCOHOL; CAFFEIC ACID PHENETHYL ESTER; PROTEOGLYCAN; CAFFEIC ACID DERIVATIVE; DRUG DERIVATIVE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHENETHYL ALCOHOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTERIOR CRUCIATE LIGAMENT; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE DEGENERATION; CONTROLLED STUDY; DRUG EFFECT; HISTOLOGY; KNEE LIGAMENT INJURY; KNEE OSTEOARTHRITIS; MORPHOLOGY; NONHUMAN; PRIORITY JOURNAL; RABBIT; ANIMAL; DISEASE COURSE; DISEASE MODEL; DRUG ANTAGONISM; EXTRACELLULAR MATRIX; HINDLIMB; INJURY; INTRAARTICULAR DRUG ADMINISTRATION; METABOLISM; PATHOLOGY;

ANIMALS; ANTERIOR CRUCIATE LIGAMENT; CAFFEIC ACIDS; CARTILAGE, ARTICULAR; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; EXTRACELLULAR MATRIX; HINDLIMB; INJECTIONS, INTRA-ARTICULAR; NF-KAPPA B; OSTEOARTHRITIS, KNEE; PHENYLETHYL ALCOHOL; PROTEOGLYCANS; RABBITS;

EID: 0036430272     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-002-0232-9     Document Type: Article

References (25)

1. Pelletier JM, Alaaeddine N, Pierre Pelletier JP (1999) Cytokines and their role in the pathophysiology of osteoarthritis. Front Biosci 4:694-703
2. Myers SL, Brandt KL, Ehlich JW, Braunstein EM, Shelbourne KD, Heck DA, Kalasinski LA (1990) Synovial inflammation in patients with early osteoarthritis of the knee. J Rheumatol 17:1662-1669
3. Lindblad S, Hedfors E (1987) Arthroscopic and immunohistologic characterization of knee joint synovitis in osteoarthritis. Arthritis Rheum 30:1081-1088
4. Caron JP, Fernandes JC, Martel-Pelletier J, Tardif G, Mineau F, Geng C, Pelletier JP (1996) Chondroprotective effect of intraarticular injections of interleukin-1 receptor antagonist in experimental osteoarthritis: Suppression of collagenase-1 expression. Arthritis Rheum 39:1535-1544
5. Plows D, Probert L, Georgopoulos S, Alexopoulou L, Kollias G (1995) The role of tumour necrosis factor (TNF) in arthritis: studies in transgenic mice. Rheumatol Eur Suppl 2:51-54
6. Taskiran D, Stefanovic-Racic M, Georgescu HI, Evans CH (1994) Nitric oxide mediates suppression of cartilage proteo-glycan synthesis by interleukin-1. Biochem Biophys Res Commun 200:142-148
7. Studer R, Jaffurs D, Stefanovic-Racic M, Robbins PD, Evans CH (1999) Nitric oxide in osteoarthritis. Osteoarthritis Cartilage 7:377-379
8. Berenbaum F (2000) Proinflammatory cytokines, prostaglandins, and the chondrocyte: Mechanisms of intracellular activation. Joint Bone Spine 67:561-564
9. Pelletier JP, Martel-Pelletier J, Abramson SB (2001) Osteoarthritis, an inflammatory disease: Potential implication for the selection of new therapeutic targets. Arthritis Rheum 44:1237-1247
10. Martel-Pelletier J (1999) Pathophysiology of osteoarthritis. Osteoarthritis Cartilage 7:371-373
11. Alaaeddine N, Di Battista JA, Pelletier JP, Kiansa K, Cloutier JM, Martel-Pelletier J (1999) Differential effects of IL-8, LIF (pro-inflammatory) and IL-11 (anti-inflammatory) on TNF-induced PGE(2) release and on signalling pathways in human OA synovial fibroblasts. Cytokine 11:1020-1030
12. Yamamoto K, Arakawa T, Ueda N, Yamamoto S (1995) Transcriptional roles of nuclear factor kappa B and nuclear factor-interleukin-6 in the tumor necrosis factor alpha-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells. J Biol Chem 29:31315-31320
13. Gilston V, Jones HW, Soo CC, Coumbe A, Blades S, Kaltschmidt C, Baeuerle PA, Morris CJ, Blake DR, Winyard PG (1997) NF-kappa B activation in human knee-joint synovial tissue during the early stage of joint inflammation. Biochem Soc Trans 25:518S
14. Natarajan K, Singh S, Burke TR Jr, Grunberger D, Aggrawal BB (1996) Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B. Proc Natl Acad Sci U S A 20:93:9090-9095
15. Ilhan A, Koltuksuz U, Ozen S, Uz E, Ciralýk H, Akyol O (1999) The effects of caffeic acid phenethyl ester (CAPE) on spinal cord ischemia/reperfusion injury in rabbits. Eur J Cardiothorac Surg 16:458-463
16. Doganay S, Turkoz Y, Evereklioglu C, Er H, Borazan M, Ozerol E (in press) The use of caffeic acid phenethyl ester to prevent sodium selenite-induced cataract in rats. J Cataract Refract Surg
17. Mirzoeva OK, Sud'ina GF, Pushkareva MA, Korshunova GA, Sumbatian NV, Varfolomeev SD (1995) Lipophilic derivatives of caffeic acid as lipoxygenase inhibitors with antioxidant properties. Russian Bioorg Chem 21:143-151
18. Grunberger D, Banerjee R, Eisinger K, Oltz EM, Efros L, Caldwell M, Estevez V, Nakanishi K (1988) Preferential cyto-toxicity on tumor cells by caffeic acid phenethyl ester isolated from propolis. Experientia 15:44:230-232
19. Plater-Zyberk C, Joosten LA, Helsen MM, Sattonnet-Roche P, Siegfried C, Alouani S, van de Loo FA, Graber P, Aloni S, Cirillo R, Lubberts E, Dinarello CA, van den Berg WB, Chvatchko Y (2001) Therapeutic effect of neutralizing endogenous IL-18 activity in the collagen-induced model of arthritis. J Clin Invest 108:1825-1832
20. Joosten LA, Lubbert E, Helsen MM, Saxne T, Coenen de Roo CJ, Heinegard D, van den Berg WB (1999) Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis. Arthritis Res 1:81-91
21. Barnes PJ, Karin M (1993) Nuclear factor-kappa B: A pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336:1066-1071
22. Barnes PJ, Adcock I (1993) Antiinflammatory actions of steroids: Molecular mechanisms. Trends Pharmacol Sci 14:436-441
23. Kopp E, Ghosh S (1994) Inhibition of NF-kappa B by sodium salicylate and aspirin. Science 12:265:956-959
24. Yamamoto Y, Yin MJ, Lin KM, Gaynor RB (1999) Sulindac inhibits activation of the NF-κB pathway. J Biol Chem 274:27307-27314
25. Scheller S, Stojko A, Szwarnowiecka I, Tustanowski J, Obuszko Z (1977) Biological properties and clinical application of propolis. VI. Investigation of the influence of ethanol extracts of propolis (EEP) on cartilaginous tissue regeneration. Arzneimittelforschung 27:2138-2140